Suggested Topics within your search.
Showing 201 - 220 results of 405 for search '"M.D."', query time: 0.10s Refine Results
  1. 201
  2. 202
  3. 203
  4. 204
  5. 205

    Effects of the New Aldose Reductase Inhibitor Benzofuroxane Derivative BF-5m on High Glucose Induced Prolongation of Cardiac QT Interval and Increase of Coronary Perfusion Pressure by C. Di Filippo, B. Ferraro, R. Maisto, M. C. Trotta, N. Di Carluccio, S. Sartini, C. La Motta, F. Ferraraccio, F. Rossi, M. D’Amico

    Published 2016-01-01
    “…This study investigated the effects of the new aldose reductase inhibitor benzofuroxane derivative 5(6)-(benzo[d]thiazol-2-ylmethoxy)benzofuroxane (BF-5m) on the prolongation of cardiac QT interval and increase of coronary perfusion pressure (CPP) in isolated, high glucose (33.3 mM D-glucose) perfused rat hearts. BF-5m was dissolved in the Krebs solution at a final concentration of 0.01 μM, 0.05 μM, and 0.1 μM. 33.3 mM D-glucose caused a prolongation of the QT interval and increase of CPP up to values of 190 ± 12 ms and 110 ± 8 mmHg with respect to the values of hearts perfused with standard Krebs solution (11.1 mM D-glucose). …”
    Get full text
    Article
  6. 206
  7. 207
  8. 208
  9. 209
  10. 210
  11. 211
  12. 212
  13. 213
  14. 214
  15. 215
  16. 216
  17. 217
  18. 218
  19. 219
  20. 220